Journal of Allergy and Clinical Immunology

Slides:

Advertisements

Similar presentations

D-dimer: A biomarker for antihistamine-resistant chronic urticaria

Advertisements

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5- year follow-up: Effectiveness of early intervention with budesonide in.

A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial Kristin Wickens, PhD,

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial Kaarina.

Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo- controlled clinical trial Peter Bager, PhD, John Arnved, MD, Steen.

The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency Rita Carsetti, MD, Maria Manuela Rosado, PhD, Simona.

Risk of an asthma exacerbation after bariatric surgery in adults

Clarification concerning amoxicillin skin testing

Alalia Berry, MD, William W. Busse, MD

Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double- blind, placebo-controlled clinical trial Mohamed H. Shamji, PhD,

Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The.

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life? Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.

Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: A randomized trial Roberto Berni Canani, MD, PhD, Rita Nocerino,

Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial Jens U. Ponikau, MD, David.

Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD

A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness Salah Gariballa, MD, Sarah Forster, MSc, Stephen.

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial Marko Kalliomäki, MD, PhD,

Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial Martin Metz, MD, Andrea Schütz, MD, Karsten Weller, MD, Marina.

A randomized multicenter study evaluating Xolair persistence of response after long- term therapy Dennis Ledford, MD, William Busse, MD, Benjamin Trzaskoma,

A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy Justin M. Skripak, MD, Scott D. Nash, MD, Hannah.

Safety of formoterol in patients with asthma: Combined analysis of data from double- blind, randomized controlled trials Harold Nelson, MD, Catherine.

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind,

Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S

High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects William Busse, MD, Sheldon Spector, MD, Karin Rosén,

Early decreases in blood eosinophil levels with reslizumab

Serum free light chains in the differential diagnosis and prognosis of primary and secondary hypogammaglobulinemia Nicolò Compagno, MD, Francesco Cinetto,

Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo- controlled clinical trial Peter Bager, PhD, John Arnved, MD, Steen.

Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1– mutated common variable immunodeficiency disease Vassilios Lougaris,

News Beyond Our Pages Journal of Allergy and Clinical Immunology

A cluster-randomized trial shows telephone peer coaching for parents reduces children's asthma morbidity Jane M. Garbutt, MB, ChB, Yan Yan, MD, PhD,

News Beyond Our Pages Journal of Allergy and Clinical Immunology

The Editors' Choice Journal of Allergy and Clinical Immunology

What is an “eosinophilic phenotype” of asthma?

Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: A randomized, double-blind clinical trial Michael Weschta, MD, Dagmar Rimek,

Autophagy: Nobel Prize 2016 and allergy and asthma research

News Beyond Our Pages Journal of Allergy and Clinical Immunology

News Beyond Our Pages Journal of Allergy and Clinical Immunology

A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children Felicia A. Rabito, PhD, MPH, John C. Carlson,

Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind,

Risk factors for Haemophilus influenzae and pneumococcal respiratory tract colonization in CVID Federica Pulvirenti, MD, PhD, Romina Camilli, BD, PhD,

A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial Kristin Wickens, PhD,

Bruce G. Bender, PhD, Alex Pedan, PhD, Laleh T. Varasteh, RPh, MSF

Therapeutic strategies to reduce asthma exacerbations

News Beyond Our Pages Journal of Allergy and Clinical Immunology

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Benjamin Chaigne, MD, Hervé Watier, MD, PhD

George Philip, MD, Carolyn M

Thunderstorm-related asthma attacks

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Short course of systemic corticosteroids in sinonasal polyposis: A double-blind, randomized, placebo-controlled trial with evaluation of outcome measures

A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously Shilpa H. Desai, BS, MD, Akhil Chouksey, MD, John Poll, RN, Melvin Berger,

Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network.

Macrolide antibiotics and asthma treatment

Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.

Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double- blind, placebo-controlled clinical trial Mohamed H. Shamji, PhD,

Janet Chou, MD, Maxim Lutskiy, MD, PhD, Erdyni Tsitsikov, PhD, Luigi D

Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria Sridharan Soundararajan, PhD, Yoko Kikuchi, DVM, Kusumam Joseph, PhD,

Environmental factors and eosinophilic esophagitis

Systemic responses after bronchial aspirin challenge in sensitive patients with asthma Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,

Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: A case-control study Jonathan I. Silverberg,

Natural history of cow’s milk allergy

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Advances in mechanisms of allergic disease in 2016

Presentation transcript:

Journal of Allergy and Clinical Immunology Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies Cinzia Milito, PhD, Federica Pulvirenti, PhD, Francesco Cinetto, PhD, Vassilios Lougaris, PhD, Annarosa Soresina, MD, Antonio Pecoraro, MD, Alessandra Vultaggio, PhD, Maria Carrabba, PhD, Giuseppe Lassandro, PhD, Alessandro Plebani, PhD, Giuseppe Spadaro, MD, Andrea Matucci, MD, Giovanna Fabio, MD, Rosa Maria Dellepiane, MD, Baldassarre Martire, MD, Carlo Agostini, PhD, Damiano Abeni, MD, Stefano Tabolli, MD, Isabella Quinti, PhD Journal of Allergy and Clinical Immunology DOI: 10.1016/j.jaci.2019.01.051 Copyright © 2019 The Authors Terms and Conditions

Journal of Allergy and Clinical Immunology DOI: (10.1016/j.jaci.2019.01.051) Copyright © 2019 The Authors Terms and Conditions

Fig 1 Trial profile. Journal of Allergy and Clinical Immunology DOI: (10.1016/j.jaci.2019.01.051) Copyright © 2019 The Authors Terms and Conditions

Fig 2 Kaplan-Meier plot. A and B, Proportion of patients remaining exacerbation free during the study time in the intervention (red line) and control (blue line) groups in the study period (T1-T3; Fig 2, A) and run-out period (T3-T4; Fig 2, B). C and D, Proportion of participants free from hospital admission (Fig 2, C) and additional antibiotic courses (Fig 2, D) in the intervention (red line) and control (blue line) groups during the study period. Journal of Allergy and Clinical Immunology DOI: (10.1016/j.jaci.2019.01.051) Copyright © 2019 The Authors Terms and Conditions

Fig 3 Absolute blood counts of WBCs, neutrophils, lymphocytes, and eosinophils over time in the treatment groups. Journal of Allergy and Clinical Immunology DOI: (10.1016/j.jaci.2019.01.051) Copyright © 2019 The Authors Terms and Conditions

Fig 4 Pathogenic bacteria analysis. A and B, Number of positive isolates from sputum samples in the azithromycin (Fig 4, A) and placebo (Fig 4, B) groups. C, Proportion of S pneumoniae and H influenzae isolates not susceptible to macrolides in the intervention (red pie chart) and placebo (blue pie chart) groups. D, Time of the appearance of macrolide resistance. Journal of Allergy and Clinical Immunology DOI: (10.1016/j.jaci.2019.01.051) Copyright © 2019 The Authors Terms and Conditions

Fig E1 IgG trough levels during the study period in the azithromycin (red line) and placebo (blue line) groups. Journal of Allergy and Clinical Immunology DOI: (10.1016/j.jaci.2019.01.051) Copyright © 2019 The Authors Terms and Conditions